NEW YORK (Reuters Health) – A Danish observational study provides no evidence that use of angiotensin receptor blockers (ARBs) is associated with an increased risk of incident cancer…
NEW YORK (Reuters Health) – Patients undergoing percutaneous coronary interventions who receive high-dose statin treatment before the procedure have about half the rate of major adverse cardiac events…
NEW YORK (Reuters Health) – Vascular complication rates are higher with an antegrade rather than retrograde femoral approach to percutaneous endovascular procedures in the lower extremities, a Michigan…
NEW YORK (Reuters Health) – It is well established that sleep disordered breathing increases the risk of heart disease. It now appears that incident cardiovascular disease is associated…
NEW YORK (Reuters Health) – Patients with osteogenesis imperfecta face an increased risk of cardiovascular abnormalities, researchers from Norway report in the March American Heart Journal. Osteogenesis imperfecta…
NEW YORK (Reuters Health) – Drugs currently available for patients with heart failure with preserved ejection fraction (HFpEF) have no mortality benefit, according to a meta-analysis published in…
NEW YORK (Reuters Health) – Adding extra protein to enteral nutrition for critically ill children is safe and may help improve their protein metabolism, Spanish researchers report. Critically…
NEW YORK (Reuters Health) – There is no conclusive evidence that anti-arryhthmic drugs extend overall survival after cardiac arrest, the authors of a new research review conclude. These…
NEW YORK (Reuters Health) – A study from Japan finds that sodium bicarbonate plus sodium chloride is more effective than sodium chloride alone for the prevention of contrast-induced…